SCHEMBL26435514

SCHEMBL26435514

c1ccc(-c2ccc(-c3nc(-c4cccc(-c5cccc6ccc7ccccc7c56)c4)nc(-c4cccc5c4oc4ccccc45)n3)c(-c3ccccc3)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.42
GGPS1 O95749 1/20 0.35
PIM1 P11309 1/20 0.34
CSNK2A2 P19784 1/20 0.34
CSNK2B P67870 1/20 0.34
PIM3 Q86V86 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
ABCG2 Q9UNQ0 3/20 0.33
PRKDC P78527 3/20 0.33
PLA2G2A P14555 1/20 0.33
PLA2G4A P47712 1/20 0.33
CYP1A1 P04798 1/20 0.33
CYP1A2 P05177 1/20 0.33
FYN P06241 1/20 0.33
MAPK3 P27361 1/20 0.33
AHR P35869 1/20 0.33
PAX8 Q06710 1/20 0.33
PTGES2 Q9H7Z7 1/20 0.33
MAPT P10636 3/20 0.33
KDM4E B2RXH2 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435617 0.96 ALOX5 (0.45) ALOX5GGPS1PIM1CSNK2A2CSNK2B
SCHEMBL26435619 0.95 ALOX5 (0.44) ALOX5GGPS1PIM1CSNK2A2CSNK2B
SCHEMBL26435608 0.94 ALOX5 (0.44) ALOX5GGPS1PIM1CSNK2A2CSNK2B
SCHEMBL26435018 0.94 ALOX5 (0.43) ALOX5GGPS1PIM1CSNK2A2CSNK2B
SCHEMBL26435686 0.94 ALOX5 (0.43) ALOX5GGPS1PIM1CSNK2A2CSNK2B
SCHEMBL26435117 0.93 ALOX5 (0.43) ALOX5GGPS1PIM1CSNK2A2CSNK2B
SCHEMBL26435566 0.92 ALOX5 (0.45) ALOX5GGPS1ABCG2PRKDCCYP1A1
SCHEMBL26435462 0.92 ALOX5 (0.44) ALOX5GGPS1ABCG2PRKDCCYP1A1
SCHEMBL26435662 0.92 ALOX5 (0.44) ALOX5GGPS1ABCG2PRKDCCYP1A1
SCHEMBL26435479 0.92 ALOX5 (0.46) ALOX5GGPS1ABCG2PRKDCCYP1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 ALOX5 1266/4885GGPS1 1604/4885PIM1 1568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.